Deferred Income Tax Expense (Benefit) of TELA Bio, Inc. from 31 Dec 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
TELA Bio, Inc. quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2024 to 31 Mar 2025.
  • TELA Bio, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $52,000.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)

TELA Bio, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $52,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1

TELA Bio, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $144,000 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.